- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means

H.R. 1539
U.S. House•In House Committee
Summary
H.R. 1539, the Medical Device Electronic Labeling Act, was introduced in the House on Feb 24, 2025 by Rep. Jay Obernolte (R) with 7 co-sponsors. It was referred to Energy And Commerce, and last saw action on Feb 24, 2025: Referred to the House Committee on Energy and Commerce.
Record
Text
H.R. 1539 has 7 co-sponsors.
hb1539/introduced-in-house.txt119 HR 1539 IH: Medical Device Electronic Labeling ActU.S. House of Representatives2025-02-24text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.I 119th CONGRESS 1st Session H. R. 1539 IN THE HOUSE OF REPRESENTATIVES February 24, 2025 Mr. Obernolte (for himself, Mr. Mullin , Mr. Crenshaw , and Ms. Craig ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILLTo amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes.1.Short titleThis Act may be cited as the Medical Device Electronic Labeling Act .2.Allowing required labeling of devices to be made available solely by electronic meansSection 502(f) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352(f) ) is amended to read as follows:(f)(1)Unless its labeling bears (A) adequate directions for use; and (B) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users, except that where any requirement of clause (A) of this subparagraph, as applied to any drug or device, is not necessary for the protection of the public health, the Secretary shall promulgate regulations exempting such drug or device from such requirement.(2)Subject to subparagraph (3), required labeling for devices (including in vitro diagnostic devices) may be made available solely by electronic means, provided that—(A)such required labeling is readily accessible to intended users of such devices;(B)the manufacturer affords intended users of such devices the opportunity to request the required labeling in paper form, and upon such request, promptly provides the requested information in paper form without additional cost; and(C)the label affixed to the device or its immediate container includes all information in compliance with this Act and the regulations thereunder or any applicable order of the Secretary under subparagraph (3)(A).(3)(A)With respect to devices for which labeling is made available solely by electronic means, the Secretary may issue an order establishing requirements in addition to, or exceptions from, the requirements under subparagraph (2) for the label affixed to a device type.(B)Notwithstanding subchapter II of chapter 5 of title 5, United States Code, such order shall be published in the Federal Register, following publication of a proposed order in the Federal Register and consideration of comments to a public docket.(C)Such order may require the label of a device to contain certain information or comply with certain conditions only if the Secretary determines such requirement is necessary to provide a reasonable assurance of the safety and effectiveness of the device..
Tracker
The tracker indicates the progress of this legislation as it moves through the legislative process.
- Introduced2025-02-24
- Passed House
- Passed Senate
- Conference
- To President
- Became Law
CRS Summary
The summaries are the Congressional Research Service’s, one per stage. Read them in full.
Introduced in House Feb 24, 2025
hb1539/introduced-in-house.mdShown Here:
Introduced in House (02/24/2025)
Medical Device Electronic Labeling Act
This bill expands the permitted use of electronic labeling of medical devices to allow directions for use and warning labels for all medical devices to be provided electronically, rather than physically (i.e., affixed to or accompanying the device or its container).
(Under current law, direction and warning labels may be provided electronically only for (1) prescription devices intended for use in health care facilities or by health care professionals, and (2) in vitro diagnostic devices intended for use in blood establishments or by health care professionals.)
Under the bill, direction and warning labels may be provided solely electronically for all medical devices so long as (1) the electronic label is readily accessible to the device’s intended users, (2) intended users may request a paper label at no additional cost, and (3) the label affixed to the device or its packaging contains all information required under current laws and regulations.
The Food and Drug Administration may issue regulations establishing additional requirements or exceptions to these provisions.
Sponsors
Rep. Jay Obernolte (R) sponsors H.R. 1539, and 7 members have co-sponsored it, 3 of them from the day it was introduced.

Rep. · R–CA-23 · Sponsor
Introduced Feb 24, 2025

Rep. · D–MN-2 · Co-sponsor
Joined Feb 24, 2025 · Original

Rep. · R–TX-2 · Co-sponsor
Joined Feb 24, 2025 · Original

Rep. · D–CA-15 · Co-sponsor
Joined Feb 24, 2025 · Original

Rep. · D–CA-50 · Co-sponsor
Joined Apr 8, 2025

Rep. · R–IA-1 · Co-sponsor
Joined Apr 28, 2025

Rep. · R–FL-12 · Co-sponsor
Joined May 6, 2025

Rep. · D–NJ-5 · Co-sponsor
Joined Mar 24, 2026
Committees
H.R. 1539 went before 1 committee: Energy and Commerce.
Actions
H.R. 1539 has taken 2 actions since Feb 24, 2025.
| Chamber | Action | |||
|---|---|---|---|---|
Feb 24, 2025 | House | Introduced in House | ||
Feb 24, 2025 | House | Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee |
Votes
H.R. 1539 has not gone to a roll call.
Titles
H.R. 1539 goes by 3 titles, 1 of them short titles.
- Medical Device Electronic Labeling Act — Display Title
- Medical Device Electronic Labeling Act — Short Title(s) as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means, and for other purposes. — Official Title as Introduced
Lobbying
10 clients hired 10 firms and 67 registered lobbyists who named H.R. 1539 in 34 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.
Filed under Health Issues, Taxation/Internal Revenue Code, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations, Veterans, Copyright/Patent/Trademark, Defense.
Clients
Who paid to be heard, by how many filings named the bill.
| Client | Business | State | Firms | Filings | Reported |
|---|---|---|---|---|---|
| DEXCOM, INC. | — | California | 1 | 6 | — |
| JOHNSON & JOHNSON SERVICES INC | — | New Jersey | 1 | 6 | — |
| MEDTRONIC INC | — | District of Columbia | 1 | 6 | — |
| ADVANCED MEDICAL TECHNOLOGY ASSN | — | District of Columbia | 1 | 4 | — |
| THE COOK GROUP INC. | — | Virginia | 1 | 4 | — |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | Trade association for medical device manufacturers. | District of Columbia | 1 | 3 | $60K |
| PHILIPS HOLDING USA INC. | — | Massachusetts | 1 | 2 | — |
| AMERICAN MEDICAL ASSOCIATION | — | District of Columbia | 1 | 1 | — |
| BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) | — | District of Columbia | 1 | 1 | — |
| ZIMMER BIOMET, INC. | — | District of Columbia | 1 | 1 | — |
Firms
Registrants who filed on the bill, by filings.
| Registrant | Clients | Filings | Reported |
|---|---|---|---|
| DEXCOM, INC. | 1 | 6 | — |
| JOHNSON & JOHNSON SERVICES, INC. | 1 | 6 | — |
| MEDTRONIC, INC. | 1 | 6 | — |
| ADVANCED MEDICAL TECHNOLOGY ASSN | 1 | 4 | — |
| THE COOK GROUP INC. | 1 | 4 | — |
| LMH STRATEGIC SOLUTIONS | 1 | 3 | $60K |
| PHILIPS HOLDING USA, INC. | 1 | 2 | — |
| AMERICAN MEDICAL ASSOCIATION | 1 | 1 | — |
| BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) | 1 | 1 | — |
| ZIMMER BIOMET, INC. | 1 | 1 | — |
Lobbyists
Named on the filings that cite the bill. The 20 named most often, of 67.
| Lobbyist | Firms | Clients | Filings |
|---|---|---|---|
| ABIGAIL PINKELE | 1 | 1 | 6 |
| AMY PELLEGRINO | 1 | 1 | 6 |
| ANDREA LOONEY | 1 | 1 | 6 |
| ASHLEY MENZLER | 1 | 1 | 6 |
| BILLY RAINES | 1 | 1 | 6 |
| COLLEEN VIVALDI | 1 | 1 | 6 |
| DAVID KAVANAUGH | 1 | 1 | 6 |
| JANE ADAMS | 1 | 1 | 6 |
| JESSICA BATTAGLIA | 1 | 1 | 6 |
| KELLY WATERS | 1 | 1 | 6 |
| KRISTINA PISANELLI | 1 | 1 | 6 |
| LARRY CAMM | 1 | 1 | 6 |
| LEIF BRIERLEY | 1 | 1 | 6 |
| MEGHAN STONE | 1 | 1 | 6 |
| TIMOTHY SWOPE | 1 | 1 | 6 |
| TODD GILLENWATER | 1 | 1 | 6 |
| WENDY SUSSMAN | 1 | 1 | 6 |
| DEANA MCRAE | 1 | 1 | 5 |
| JULIA KALUSNIAK | 1 | 1 | 5 |
| ALLISON GILES | 1 | 1 | 4 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.
| Client | Registrant | Period | Reported | Document |
|---|---|---|---|---|
| AMERICAN MEDICAL ASSOCIATION | AMERICAN MEDICAL ASSOCIATION | 2025 first_quarter | $8M | 1st Quarter - Report |
| JOHNSON & JOHNSON SERVICES INC | JOHNSON & JOHNSON SERVICES, INC. | 2026 first_quarter | $3.5M | 1st Quarter - Report |
| JOHNSON & JOHNSON SERVICES INC | JOHNSON & JOHNSON SERVICES, INC. | 2025 first_quarter | $3.3M | 1st Quarter - Report |
| JOHNSON & JOHNSON SERVICES INC | JOHNSON & JOHNSON SERVICES, INC. | 2025 third_quarter | $2.5M | 3rd Quarter - Report |
| MEDTRONIC INC | MEDTRONIC, INC. | 2025 third_quarter | $2.1M | 3rd Quarter - Report |
| JOHNSON & JOHNSON SERVICES INC | JOHNSON & JOHNSON SERVICES, INC. | 2025 fourth_quarter | $1.5M | 4th Quarter - Report |
| JOHNSON & JOHNSON SERVICES INC | JOHNSON & JOHNSON SERVICES, INC. | 2026 second_quarter | $1.4M | 2nd Quarter - Report |
| MEDTRONIC INC | MEDTRONIC, INC. | 2026 second_quarter | $1.2M | 2nd Quarter - Report |
| ADVANCED MEDICAL TECHNOLOGY ASSN | ADVANCED MEDICAL TECHNOLOGY ASSN | 2026 first_quarter | $1.1M | 1st Quarter - Report |
| JOHNSON & JOHNSON SERVICES INC | JOHNSON & JOHNSON SERVICES, INC. | 2025 second_quarter | $1M | 2nd Quarter - Report |
| MEDTRONIC INC | MEDTRONIC, INC. | 2025 fourth_quarter | $990K | 4th Quarter - Report |
| ADVANCED MEDICAL TECHNOLOGY ASSN | ADVANCED MEDICAL TECHNOLOGY ASSN | 2026 second_quarter | $971K | 2nd Quarter - Report |
| MEDTRONIC INC | MEDTRONIC, INC. | 2025 first_quarter | $970K | 1st Quarter - Report |
| ADVANCED MEDICAL TECHNOLOGY ASSN | ADVANCED MEDICAL TECHNOLOGY ASSN | 2025 fourth_quarter | $942K | 4th Quarter - Report |
| MEDTRONIC INC | MEDTRONIC, INC. | 2026 first_quarter | $940K | 1st Quarter - Report |
| ADVANCED MEDICAL TECHNOLOGY ASSN | ADVANCED MEDICAL TECHNOLOGY ASSN | 2025 third_quarter | $860K | 3rd Quarter - Report |
| PHILIPS HOLDING USA INC. | PHILIPS HOLDING USA, INC. | 2025 second_quarter | $720K | 2nd Quarter - Report |
| MEDTRONIC INC | MEDTRONIC, INC. | 2025 second_quarter | $650K | 2nd Quarter - Report |
| PHILIPS HOLDING USA INC. | PHILIPS HOLDING USA, INC. | 2026 second_quarter | $640K | 2nd Quarter - Report |
| DEXCOM, INC. | DEXCOM, INC. | 2025 fourth_quarter | $390K | 4th Quarter - Report |
Classification
The Congressional Research Service files H.R. 1539 under Health, one of its 31 policy areas, and gives it 3 legislative subjects.
CRS Subjects
CRS assigns every bill one policy area from its 31; H.R. 1539’s is Health.
hr1539/policy-areas.txtLegislative Subjects
H.R. 1539 carries 3 of CRS’s legislative subjects, from Computers and information technology to Drug safety, medical device, and laboratory regulation.
hr1539/subjects.txtConstitutional authority
The clause the sponsor cites as Congress’s power to enact H.R. 1539, as entered in the Congressional Record.
[Congressional Record Volume 171, Number 36 (Monday, February 24, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. OBERNOLTE:H.R. 1539.Congress has the power to enact this legislation pursuantto the following:Article 1 section 8[Page H769]
Source: congress.gov · legiscan.com